… Author links open overlay panel Bing Chen MD a , Lauren V. Collen MD b , Craig Mowat
MD c , Kim L. Isaacs MD d , Siddharth Singh MD, MS e , Sunanda V. Kane MD e , Francis A. …

Background and Aims Over 80 monogenic causes of very early onset inflammatory bowel
disease [VEOIBD] have been identified. Prior reports of the natural history of VEOIBD have not …

Lay Summary A pediatric patient with Crohn’s disease refractory to anti-tumor necrosis
factor therapy, vedolizumab, ustekinumab, and 6-mercaptopurine achieved rapid clinical …

Background Very early onset inflammatory bowel disease (VEOIBD) is defined as disease
onset in patients younger than 6 years. Challenges in treatment of VEOIBD include lack of …

Glycogen storage disease type 1b (GSD1b) is associated with inflammatory bowel disease
and congenital neutropenia. Neutropenia in GSD1b is caused by the accumulation of 1, 5-…

Primary immunodeficiency may present with treatment-refractory enteropathy. We present
two patients with celiac/celiac-like disease diagnosed in early childhood and refractory to the …

Monogenic causes of inflammatory bowel diseases (IBD) are increasingly being discovered.
To date, much attention has been placed in those resulting from inborn errors of immunity. …

Objective: The objective of this study is (1) to describe the prevalence of pancreatitis-associated
medication (PAM) use at admission and discharge in pediatric and young adult patients …

To the Editors, In their letter, Watson et al report on antitumor necrosis factor (anti-TNF)
failure in the Texas Children’s Hospital very early onset inflammatory bowel disease (VEOIBD) …

Objectives: To describe clinical characteristics and outcomes of 3 patients with very early
onset inflammatory bowel disease (VEOIBD) and vertebral compression fractures. Methods: …